INTRODUCTION
The search for new drug candidates with more bioactivity potential is a key research interest in synthetic organic chemistry [1] . The derivatives of heterocyclic compounds have been found to be bioactive, including naturally occurring and synthetically prepared ones [2] . Among these compounds, 1,3,4-oxadiazole derivatives have been synthesized and evaluated for a number of biological activities including antidepressant, anticonvulsant, anticancer, antimicrobial, etc., during the last two decades [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Another bioactive heterocyclic moiety, piperidine or azinane, is found to be a part of many natural and synthetic bioactive compounds [12] . Furthermore, this moiety has applications as food additives, solvents, curing agents for rubber and intermediates for inorganic synthesis [13, 14] . These different bioactive heterocyclic moieties have been included as a single unit in target molecules with the aim of possibly enhancing their antibacterial potential.
EXPERIMENTAL General
Chemical reagents were purchased from Sigma Aldrich and Alfa Aesar through local suppliers. The solvents of analytical grade were also obtained from local suppliers. The purity of final compounds was verified by thin-layer chromatography (TLC) performed on silica gelcoated aluminum plates. n-Hexane and ethyl acetate were employed as the mobile phase. The TLC plates were visualized under a UV 254 lamp. A Griffin and George apparatus was used to determine melting points, which were uncorrected. A Jasco-320-A spectrophotometer, Bruker spectrometer and JMS-HX-110 spectrometer were used to record IR (potassium bromide pellet method), 
Synthesis of ethyl 1-[(4-chlorophenyl) sulfonyl]piperidin-4-carboxylate (3)
4-Chlorobenzenesulfonyl chloride (1; 0.05 mol) was stirred with ethyl piperidin-4-carboxylate (2; 0.05 mol) in water for 3 hours. The pH was adjusted to 9 -10 with 15 % Na 2 CO 3 during the reaction. The reaction was monitored by TLC. Chilled distilled water was added to the reaction mixture to obtain the precipitate of compound 3. The formed precipitate was collected by filtration, washed and dried.
Synthesis of 1-[(4-chlorophenyl)sulfonyl] piperidin-4-carbohydrazide (4)
Compound 3 (0.04 mol) was refluxed with hydrazine hydrate (0.04 mol) in ethanol for 2.5 hours. The reaction was monitored by TLC. After addition of distilled water, the precipitate was obtained by filtration, washed and dried at room temperature.
Synthesis of 5-[1-(4-chlorophenylsulfonyl)-4-piperidinyl]-1,3,4-oxadiazol-2-thiol (5)
Potassium hydroxide (0.04 mol) and carbon disulfide (0.08 mol) were refluxed for 5 hours with compound 4 (0.04 mol) in ethanol. The reaction was monitored by TLC. Cold distilled water and dilute HCl (to adjust pH to 2 -3) were added to precipitate the target compound. The product was obtained by filtration, washed, dried and recrystallized from methanol.
Synthesis of N-aryl-2-bromoacetamides (7a-n)
Aryl amines (6a-n; 0.02 mol) were stirred with 2-bromoacetyl bromide (0.02 mol) in distilled water for 1 hour. The pH was maintained at 9 -10 with 15 % Na 2 CO 3 during the reaction. Completion of reaction was confirmed by TLC. The product was obtained after filtration, washing and drying.
Synthesis of 5-{1-[(4-chlorophenyl)sulfonyl] piperidin-4-yl}-2-{[N-(substituted)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8a-n)
Compound 5 (0.005 mol) was stirred with LiH (0.005 mol) in DMF for half an hour. Equimolar N-aryl-2-bromoacetamides (7a-n) were added and the mixture was stirred for 3 -4 hours. Completion of reaction was monitored by TLC. Cold distilled water was added to form the precipitate, which was filtered out, washed and dried.
Antibacterial activity assay
The antibacterial activity assay was performed according to the protocol reported in the literature [15] [16] [17] , in sterile 96-well microplates under aseptic conditions. The increase in absorbance of broth medium was noted which is directly related to log phase of microbial growth.
Statistical analysis
Statistical analysis using Microsoft Excel 2010 was based on three independent experiments, and the results are expressed as mean ± SEM. The minimum inhibitory concentration (MIC) was determined with suitable dilutions (5 -30 µg/well) for each compound and the results were analyzed using EZ-Fit software (Perrella Scientific Inc, Amherst, USA). The statistical analysis included 85 % CL.
RESULTS
The protocol for synthesis of some new Nsubstituted acetamide derivatives of azinane bearing 1,3,4-oxadiazole is elaborated in Figure 1 and different N-substituted groups are given in Table 1 . The spectral characterization of synthesized compounds is described below. 
Spectral characterization of synthesized molecules (8a-n)

5-{1-[(4-Chlorophenyl)sulfonyl]piperidin-4-yl}-2-{[N-(2,4-dimethylphenyl)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8a)
2.8 Hz, 2H, H a -2' & H a -6'), 2.26 (s, 3H, CH 3 -4""), 2.15 (s, 3H, CH 3 -2""), 2.14-2.12 (m, 2H, H e -3' & H e -5'), 1.99-1.96 (m, 2H, H a -3' & H a -5'); 13 C-NMR (CDCl 3 , 100 MHz): δ (ppm) 169.4 (C-5), 165.3 (C-2), 165.1 (C-1"'), 139.5 (C-1"), 135.1 (C-4"), 134.8 (C-1""), 132.9 (C-2""), 132.4 (C-4""), 131.2 (C-5""), 129.5 (C-3" & C-5"), 129.0 (C-2" & C-6"), 127.2 (C-3""), 122.6 (C-6""), 44.9 (C-2' & C-6'), 35.9 (C-2"'), 32.4 (C-4'), 28.1 (C-3' & C-5'), 20.8 (CH 3 -4""),
5-{1-[(4-Chlorophenyl)sulfonyl]piperidin-4-yl}-2-{[N-(2,3-dimethylphenyl)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8b)
5-{1-[(4-Chlorophenyl)sulfonyl]piperidin-4-yl}-2-{[N-(3,5-dimethylphenyl)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8f)
5-{1-[(4-Chlorophenyl)sulfonyl]piperidin-4-yl}-2-{[N-(2-methylphenyl)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8g)
5-{1-[(4-Chlorophenyl)sulfonyl]piperidin-4-yl}-2-{[N-(2-ethylphenyl)-2-acetamoyl]thio]}-1,3,4-oxadiazole (8i)
Antibacterial activity
The results of antibacterial activity are given as % inhibition and MIC in Table 2 and Table 3 , respectively. The synthesized compounds exhibited better activity against the Gramnegative bacterial strains used. Compound 8g bearing a 2-methylphenyl group was the most active against all the Gram-negative bacterial strains considered and one of the Gram-positive bacterial strains.
DISCUSSION
Compound 8a was a white amorphous solid with a melting point of 139-140 °C, showing a yield of 84 %. Its molecular mass was justified by the molecular ion peak at m/z 521 with an isotopic peak at m/z 523. The molecular formula was well supported by EIMS spectrum and the proton integration curves in 
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